Analysis of the MAVIDOS trial - Author's reply.
Saved in:
| Title: | Analysis of the MAVIDOS trial - Author's reply. |
|---|---|
| Authors: | Harvey NC; Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., Moon RJ; Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Inskip HM; Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., Godfrey KM; Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., Cooper C; Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. Electronic address: cc@mrc.soton.ac.uk. |
| Corporate Authors: | MAVIDOS Trial Group |
| Source: | The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2017 May; Vol. 5 (5), pp. 328-329. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
